Novartis (NVS) said Wednesday it plans to expand its operations in North Carolina to create a new manufacturing hub with end-to-end manufacturing capabilities.
The hub, part of its $23 billion investment in US infrastructure over the next five years, is to ensure all key medicines for US patients are manufactured in the US, the company said.
The expansion includes building a new site in Durham with two new facilities for manufacturing biologics and sterile packaging, Novartis said. The hub is expected to open in 2027-2028.
Price: 126.82, Change: -1.19, Percent Change: -0.93
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments